![Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine](https://www.thelancet.com/cms/asset/92fa2a4c-e9e8-42b6-be07-cb3711d901e7/gr1.jpg)
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
![CA 50 blood test, a tumor marker for gastrointestinal malignancies diagnosis. 8931029 Stock Photo at Vecteezy CA 50 blood test, a tumor marker for gastrointestinal malignancies diagnosis. 8931029 Stock Photo at Vecteezy](https://static.vecteezy.com/system/resources/previews/008/931/029/large_2x/ca-50-blood-test-a-tumor-marker-for-gastrointestinal-malignancies-diagnosis-photo.jpg)
CA 50 blood test, a tumor marker for gastrointestinal malignancies diagnosis. 8931029 Stock Photo at Vecteezy
![ESMO17. STUDIU: Determinarea în exces a markerilor tumorali produce anxietate pacienților și determină costuri inutile ESMO17. STUDIU: Determinarea în exces a markerilor tumorali produce anxietate pacienților și determină costuri inutile](https://raportuldegarda.ro/wp-content/uploads/2017/09/markeri_tumori_localizare.jpg)
ESMO17. STUDIU: Determinarea în exces a markerilor tumorali produce anxietate pacienților și determină costuri inutile
![Premium Photo | Scientist holds blood sample for ca 50 blood test. a tumor marker for gastrointestinal malignancies. Premium Photo | Scientist holds blood sample for ca 50 blood test. a tumor marker for gastrointestinal malignancies.](https://img.freepik.com/premium-photo/scientist-holds-blood-sample-ca-50-blood-test-tumor-marker-gastrointestinal-malignancies_196584-530.jpg?w=2000)
Premium Photo | Scientist holds blood sample for ca 50 blood test. a tumor marker for gastrointestinal malignancies.
![SMAD4/DPC4 (Pancreatic Adenocarcinoma Marker/Tumor Suppressor) Recombinant Monoclonal Antibody (SMAD/6309R) (4089-RBM19-P0) SMAD4/DPC4 (Pancreatic Adenocarcinoma Marker/Tumor Suppressor) Recombinant Monoclonal Antibody (SMAD/6309R) (4089-RBM19-P0)](https://www.thermofisher.com/antibody/images/650/4089-RBM19-P0-SMAD4-IHC-1-20230720_140117.jpg?time=20220826?time=20220826)
SMAD4/DPC4 (Pancreatic Adenocarcinoma Marker/Tumor Suppressor) Recombinant Monoclonal Antibody (SMAD/6309R) (4089-RBM19-P0)
![Molecules | Free Full-Text | Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer Molecules | Free Full-Text | Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer](https://www.mdpi.com/molecules/molecules-27-04578/article_deploy/html/images/molecules-27-04578-g001.png)
Molecules | Free Full-Text | Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
![The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/35/10/5519/F1.large.jpg)